Diagnosing by probe where cardiac arrhythmias occur

These are considered to be one of the main causes of sudden cardiac death. In the project Multimodal Fiber Optic Probe for Highly Resolved in Vivo Localization of Cardiac Fibrosis (MultiFib), project manager Iwan Schie, Ines Latka and David Vazquez from Leibniz IPHT are collaborating with partners from the Medical University of Vienna and the Institut de Rythmologie et modélisation Cardiaque (Liryc) of Bordeaux. “We want to develop special catheters that can be used where the arrhythmia occur,” explains Iwan Schie. “At the same time, they are to monitor in real time during the operation whether the ablation therapy is successful. Doctors use this minimally invasive procedure to destroy abnormal tissue. The European Commission is funding MultiFib under the ERA-NET programme in Horizon 2020 until April 2021.